CUAMC
China Universal Asset Management Company’s Aclaris Therapeutics ACRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-13,722
| Closed | -$15.8K | – | 497 |
|
|
2024
Q3 | $15.8K | Buy |
13,722
+5,350
| +64% | +$6.15K | ﹤0.01% | 412 |
|
|
2024
Q2 | $9.21K | Sell |
8,372
-5,255
| -39% | -$5.78K | ﹤0.01% | 400 |
|
|
2024
Q1 | $16.9K | Buy |
13,627
+5,431
| +66% | +$6.73K | ﹤0.01% | 429 |
|
|
2023
Q4 | $8.61K | Buy |
8,196
+6,382
| +352% | +$6.7K | ﹤0.01% | 416 |
|
|
2023
Q3 | $12.4K | Buy |
1,814
+888
| +96% | +$6.08K | ﹤0.01% | 335 |
|
|
2023
Q2 | $9.6K | Buy |
926
+23
| +3% | +$239 | ﹤0.01% | 321 |
|
|
2023
Q1 | $7.31K | Buy |
903
+225
| +33% | +$1.82K | ﹤0.01% | 333 |
|
|
2022
Q4 | $10.7K | Buy |
678
+54
| +9% | +$851 | ﹤0.01% | 222 |
|
|
2022
Q3 | $10K | Buy |
+624
| New | +$10K | ﹤0.01% | 201 |
|